Artrya Limited
Status: Publicly traded
Direct answer
Artrya Limited is publicly traded on ASX under the ticker AYA.AX.
Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in...
Can you invest in Artrya Limited?
Yes. Artrya Limited is publicly traded on ASX under the ticker AYA.AX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Artrya Limited
Detailed equity research is provided by MarketSnap.